News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,641 Results
Type
Article (88941)
Company Profile (555)
Press Release (796126)
Multimedia
Podcasts (245)
Webinars (36)
Section
Business (267066)
Career Advice (4164)
Deals (40026)
Drug Delivery (181)
Drug Development (91782)
Employer Resources (207)
FDA (18601)
Job Trends (17497)
News (398894)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (243)
Alzheimer's disease (2022)
Antibody-drug conjugate (ADC) (589)
Approvals (18993)
Artificial intelligence (918)
ASCO (345)
Autoimmune disease (384)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (261)
Biotechnology (336)
Bladder cancer (218)
Brain cancer (86)
Breast cancer (861)
Cancer (6805)
Cardiovascular disease (574)
Career advice (3601)
Career pathing (53)
CAR-T (395)
CDC (77)
Celiac Disease (3)
Cell therapy (1108)
Cervical cancer (58)
Clinical research (79387)
Collaboration (2471)
Commercialization (1)
Company closure (8)
Compensation (1595)
Complete response letters (114)
COVID-19 (3046)
CRISPR (130)
C-suite (1362)
Cystic fibrosis (170)
Data (9005)
Decentralized trials (3)
Denatured (94)
Depression (205)
Dermatology (105)
Diabetes (729)
Diagnostics (7651)
Digital health (73)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (462)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (334)
Earnings (102575)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139004)
Executive appointments (1227)
FDA (22877)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2024)
Gene editing (284)
Generative AI (93)
Gene therapy (873)
GLP-1 (1300)
Government (5571)
Grass and pollen (8)
Guidances (426)
Healthcare (21275)
Hematology (198)
HIV (100)
Huntington's disease (71)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (119)
Immunology and inflammation (368)
Immuno-oncology (122)
Indications (226)
Infectious disease (3456)
Inflammatory bowel disease (247)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (333)
Interviews (822)
IPO (18014)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (696)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (898)
Lymphoma (492)
Machine learning (70)
Management (68)
Manufacturing (1306)
Marketing (5)
MASH (231)
Medical affairs (1)
Medical device (15309)
Medtech (15501)
Mergers & acquisitions (23367)
Metabolic disorders (1879)
mRNA (281)
Multiple sclerosis (214)
NASH (24)
Neurodegenerative disease (539)
Neuropsychiatric disorders (132)
Neuroscience (3846)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5146)
Now hiring (84)
Obesity (892)
Opinion (382)
Ovarian cancer (252)
Pain (292)
Pancreatic cancer (375)
Parkinson's disease (431)
Partnered (42)
Patents (686)
Patient recruitment (828)
Peanut (72)
People (68205)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24527)
Phase 2 (34481)
Phase 3 (25932)
Pipeline (10379)
Policy (406)
Postmarket research (3561)
Preclinical (11006)
Press Release (72)
Prostate cancer (358)
Psychedelics (75)
Radiopharmaceuticals (381)
Rare diseases (1341)
Real estate (7463)
Recruiting (82)
Regulatory (30695)
Reports (77)
Research institute (2775)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (251)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (148)
Vaccines (1337)
Venture capital (143)
Weight loss (607)
Women's health (147)
Worklife (25)
Date
Today (52)
Last 7 days (466)
Last 30 days (2026)
Last 365 days (33212)
2026 (18266)
2025 (33215)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (103)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52453)
Australia (9218)
California (14710)
Canada (4141)
China (1658)
Colorado (633)
Connecticut (649)
Delaware (452)
Europe (120960)
Florida (2217)
Georgia (478)
Hawaii (4)
Idaho (70)
Illinois (1290)
India (110)
Indiana (674)
Iowa (25)
Japan (628)
Kansas (144)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1768)
Massachusetts (10767)
Michigan (427)
Minnesota (818)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (158)
New Hampshire (92)
New Jersey (3894)
New Mexico (35)
New York (3889)
North Carolina (1951)
North Dakota (11)
Northern California (7347)
Ohio (458)
Oklahoma (27)
Oregon (46)
Pennsylvania (2884)
Puerto Rico (33)
Rhode Island (53)
South America (1669)
South Carolina (91)
South Dakota (2)
Southern California (5802)
Tennessee (241)
Texas (2387)
United States (52548)
Utah (442)
Vermont (2)
Virginia (369)
Washington D.C. (88)
Washington State (1193)
West Virginia (4)
Wisconsin (159)
Wyoming (2)
There are 885,641 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
EMD Serono trims R&D workforce by 70
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
July 13, 2026
·
67 min read
·
BioSpace Editorial Staff
Immunology and inflammation
AB Science ends three studies in multiple sclerosis, other immune conditions
The trials, which were testing the tyrosine kinase inhibitor masitinib, had previously been paused. AB Science’s decision not to resume them was a matter of prioritization, not safety, the biotech said.
July 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
INDIANA UNIVERSITY AND PHARMATROPHIX PRESENT FINDINGS ON PERFORMANCE OF ORAL THERAPEUTIC, LM11A-31, TO REDUCE DECLINE OF BRAIN FUNCTIONAL-NETWORK CONNECTIVITY IN ALZHEIMER’S DISEASE
July 13, 2026
·
6 min read
Complete response letters
FDA posts new rejection letters days after confirming pause
The FDA last week confirmed that it would suspend the release of complete response letters pending the resolution of a citizen petition from an unnamed pharma company. Nevertheless, 14 new CRLs are now available on the agency’s portal.
July 13, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
July 13, 2026
·
6 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
·
4 min read
Press Releases
Sofinnova Partners Appoints David Evans as Partner
July 13, 2026
·
3 min read
Press Releases
Bora Biologics Expands U.S. Commercial Manufacturing Platform with Addition of Rockville Site
July 13, 2026
·
3 min read
Press Releases
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
July 13, 2026
·
11 min read
Press Releases
Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
July 13, 2026
·
7 min read
1 of 88,565
Next
